Guided Therapeutics (Norcross, Georgia), a developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, says it has answered all of FDA's key questions ...
GRAIL, Inc. GRAL announced the submission of the final module of its premarket approval application to the FDA for the Galleri multi-cancer early detection (MCED) test. The FDA had previously granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results